Semaglutide News

Semaglutide 2·4 mg Found Safe and Effective in Patients With Overweight or Obesity - Docwire News

Semaglutide 2·4 mg Found Safe and Effective in Patients With Overweight or Obesity Docwire News

Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis - Nature

Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis Nature

Is there a best day to take GLP-1 drugs? Researchers looked for an answer - News-Medical

Is there a best day to take GLP-1 drugs? Researchers looked for an answer News-Medical

Surprising Signal for Semaglutide in Bipolar Disorder - Medscape

Surprising Signal for Semaglutide in Bipolar Disorder Medscape

Generic semaglutide could reshape diabetes drug coverage in Canada - hospitalnews.com

Generic semaglutide could reshape diabetes drug coverage in Canada hospitalnews.com

Oral Semaglutide for Weight Loss: Key Facts About the Wegovy Pill - GoodRx

Oral Semaglutide for Weight Loss: Key Facts About the Wegovy Pill GoodRx

Semaglutide sustains lower calorie intake for more than a year - Penn Medicine

Semaglutide sustains lower calorie intake for more than a year Penn Medicine

Ascletis Doses First Patient in ASC30 Phase III Obesity Trial - The Clinical Trial Vanguard

Ascletis Doses First Patient in ASC30 Phase III Obesity Trial The Clinical Trial Vanguard

Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump - Reuters

Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump Reuters

About a Quarter of Those Who Stop Wegovy Start Again - MedPage Today

About a Quarter of Those Who Stop Wegovy Start Again MedPage Today

Weekly Recap: 77% 2025 sales patent risk and GLP-1 employer coverage drop - TradingView

Weekly Recap: 77% 2025 sales patent risk and GLP-1 employer coverage drop TradingView

Ozempic does something unexpected to the brain’s hunger neurons - Science Daily

Ozempic does something unexpected to the brain’s hunger neurons Science Daily

Semaglutide Does Not Increase AMD Progression Risk in Type 2 Diabetes, Study Says - Ophthalmology Advisor

Semaglutide Does Not Increase AMD Progression Risk in Type 2 Diabetes, Study Says Ophthalmology Advisor

Semaglutide Market Size, Share, Demand, Forecast, 2034 - Fortune Business Insights

Semaglutide Market Size, Share, Demand, Forecast, 2034 Fortune Business Insights

UK study to look at semaglutide for alcohol addiction and obesity - The Pharmaceutical Journal

UK study to look at semaglutide for alcohol addiction and obesity The Pharmaceutical Journal

Why You Might Tolerate One Weight Loss Drug Better Than Another, According to Experts - Health.com

Why You Might Tolerate One Weight Loss Drug Better Than Another, According to Experts Health.com

Semaglutide cardiovascular outcomes align more closely with attained dose than achieved weight loss - Nature

Semaglutide cardiovascular outcomes align more closely with attained dose than achieved weight loss Nature

Semaglutide attenuates neuroinflammation in male mice - Nature

Semaglutide attenuates neuroinflammation in male mice Nature

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial - Nature

Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial Nature

Semaglutide slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy - Nature

Semaglutide slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy Nature

Sandoz confirms regulatory approval for new semaglutide treatment option in Brazil, paving way to expand patient access - Sandoz

Sandoz confirms regulatory approval for new semaglutide treatment option in Brazil, paving way to expand patient access Sandoz

Tirzepatide vs. Semaglutide: What You Should Know - Cleveland Clinic Health Essentials

Tirzepatide vs. Semaglutide: What You Should Know Cleveland Clinic Health Essentials

Semaglutide (Wegovy) for the Treatment of Obesity - American Academy Of Family Physicians | AAFP

Semaglutide (Wegovy) for the Treatment of Obesity American Academy Of Family Physicians | AAFP

Pilot study of epigenetic aging and treatment response to semaglutide in the SLIM LIVER study | npj Aging - Nature

Pilot study of epigenetic aging and treatment response to semaglutide in the SLIM LIVER study | npj Aging Nature

Repeated semaglutide treatment attenuates cocaine-vs-food choice in male and female rats - Nature

Repeated semaglutide treatment attenuates cocaine-vs-food choice in male and female rats Nature

Study Finds No Statistical Link Between Use of Semaglutide and Other GLP-1 Drugs and Risk of Degenerative Eye Disease in Adults with Type 2 Diabetes - Johns Hopkins Medicine

Study Finds No Statistical Link Between Use of Semaglutide and Other GLP-1 Drugs and Risk of Degenerative Eye Disease in Adults with Type 2 Diabetes Johns Hopkins Medicine

Injectable Semaglutide Shows Early Promise to Improve Fertility in Women with PMOS - University of Colorado Anschutz

Injectable Semaglutide Shows Early Promise to Improve Fertility in Women with PMOS University of Colorado Anschutz

Semaglutide drives weight loss through cAMP-dependent mechanisms in GLP1R-expressing hindbrain neurons - Nature

Semaglutide drives weight loss through cAMP-dependent mechanisms in GLP1R-expressing hindbrain neurons Nature

Semaglutide With B12: Benefits And Weight Loss, According To Experts - Forbes

Semaglutide With B12: Benefits And Weight Loss, According To Experts Forbes

Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence - Cureus

Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence Cureus

Semaglutide dose may matter more than weight loss for heart health - News-Medical

Semaglutide dose may matter more than weight loss for heart health News-Medical

Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial - The Lancet

Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial The Lancet

GLP-1 Drug Semaglutide Substantially Reduced Heavy Alcohol Consumption and Weight in Patients with Alcohol Use Disorder and Obesity - Brain and Behavior Research

GLP-1 Drug Semaglutide Substantially Reduced Heavy Alcohol Consumption and Weight in Patients with Alcohol Use Disorder and Obesity Brain and Behavior Research

Wegovy, weight loss and cardiovascular health: A closer look at how semaglutide protects the heart - Cardiovascular Business

Wegovy, weight loss and cardiovascular health: A closer look at how semaglutide protects the heart Cardiovascular Business

What Is Compounded Semaglutide, And Is It Safe? - Forbes

What Is Compounded Semaglutide, And Is It Safe? Forbes

Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial - Nature

Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial Nature

UT San Antonio study: As FDA approved semaglutide for weight management, calls to poison control centers skyrocketed in the U.S. - UT San Antonio Today

UT San Antonio study: As FDA approved semaglutide for weight management, calls to poison control centers skyrocketed in the U.S. UT San Antonio Today